nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanidine—KCNB1—pulmonary artery—systemic scleroderma	0.0738	0.185	CbGeAlD
Guanidine—KCNA5—pulmonary artery—systemic scleroderma	0.0486	0.122	CbGeAlD
Guanidine—KCNS3—pulmonary artery—systemic scleroderma	0.0475	0.119	CbGeAlD
Guanidine—KCNA5—artery—systemic scleroderma	0.018	0.0451	CbGeAlD
Guanidine—KCNA7—tendon—systemic scleroderma	0.012	0.0301	CbGeAlD
Guanidine—KCNA10—lung—systemic scleroderma	0.0118	0.0297	CbGeAlD
Guanidine—KCNB1—smooth muscle tissue—systemic scleroderma	0.00999	0.025	CbGeAlD
Guanidine—KCNA3—digestive system—systemic scleroderma	0.00745	0.0187	CbGeAlD
Guanidine—KCNA5—connective tissue—systemic scleroderma	0.00719	0.018	CbGeAlD
Guanidine—DLG4—tendon—systemic scleroderma	0.00674	0.0169	CbGeAlD
Guanidine—KCNA5—smooth muscle tissue—systemic scleroderma	0.00658	0.0165	CbGeAlD
Guanidine—KCNC4—tendon—systemic scleroderma	0.00645	0.0162	CbGeAlD
Guanidine—Azotaemia—Mycophenolate mofetil—systemic scleroderma	0.00641	0.0107	CcSEcCtD
Guanidine—KCNS3—skin of body—systemic scleroderma	0.00636	0.0159	CbGeAlD
Guanidine—Throat sore—Leflunomide—systemic scleroderma	0.0063	0.0105	CcSEcCtD
Guanidine—Oropharyngeal discomfort—Leflunomide—systemic scleroderma	0.00624	0.0104	CcSEcCtD
Guanidine—KCNA3—lung—systemic scleroderma	0.00622	0.0156	CbGeAlD
Guanidine—KCNQ4—tendon—systemic scleroderma	0.0062	0.0155	CbGeAlD
Guanidine—KCNQ5—tendon—systemic scleroderma	0.00603	0.0151	CbGeAlD
Guanidine—Throat sore—Mycophenolic acid—systemic scleroderma	0.00601	0.01	CcSEcCtD
Guanidine—Gastric irritation—Prednisone—systemic scleroderma	0.00597	0.00994	CcSEcCtD
Guanidine—Oropharyngeal discomfort—Mycophenolic acid—systemic scleroderma	0.00595	0.00991	CcSEcCtD
Guanidine—Vascular purpura—Pentoxifylline—systemic scleroderma	0.0059	0.00982	CcSEcCtD
Guanidine—KCNC4—lung—systemic scleroderma	0.00566	0.0142	CbGeAlD
Guanidine—KCND1—lung—systemic scleroderma	0.00566	0.0142	CbGeAlD
Guanidine—KCNF1—tendon—systemic scleroderma	0.00552	0.0138	CbGeAlD
Guanidine—Purpura—Pentoxifylline—systemic scleroderma	0.00547	0.00911	CcSEcCtD
Guanidine—Throat sore—Lisinopril—systemic scleroderma	0.00541	0.00901	CcSEcCtD
Guanidine—Oropharyngeal discomfort—Lisinopril—systemic scleroderma	0.00536	0.00893	CcSEcCtD
Guanidine—Petechiae—Mycophenolic acid—systemic scleroderma	0.00526	0.00876	CcSEcCtD
Guanidine—KCNA5—digestive system—systemic scleroderma	0.00519	0.013	CbGeAlD
Guanidine—Oropharyngeal pain—Leflunomide—systemic scleroderma	0.00499	0.00831	CcSEcCtD
Guanidine—KCNA5—tendon—systemic scleroderma	0.00494	0.0124	CbGeAlD
Guanidine—KCNF1—lung—systemic scleroderma	0.00485	0.0121	CbGeAlD
Guanidine—KCNS3—tendon—systemic scleroderma	0.00484	0.0121	CbGeAlD
Guanidine—Oropharyngeal pain—Mycophenolic acid—systemic scleroderma	0.00476	0.00793	CcSEcCtD
Guanidine—RNASE1—tendon—systemic scleroderma	0.0047	0.0118	CbGeAlD
Guanidine—GAMT—tendon—systemic scleroderma	0.00457	0.0114	CbGeAlD
Guanidine—Epigastric discomfort—Prednisone—systemic scleroderma	0.00441	0.00733	CcSEcCtD
Guanidine—KCNA5—lung—systemic scleroderma	0.00434	0.0109	CbGeAlD
Guanidine—Oropharyngeal pain—Lisinopril—systemic scleroderma	0.00429	0.00714	CcSEcCtD
Guanidine—KCNS3—lung—systemic scleroderma	0.00425	0.0106	CbGeAlD
Guanidine—KCNQ3—lung—systemic scleroderma	0.00425	0.0106	CbGeAlD
Guanidine—Petechiae—Mycophenolate mofetil—systemic scleroderma	0.00415	0.00691	CcSEcCtD
Guanidine—RNASE1—lung—systemic scleroderma	0.00412	0.0103	CbGeAlD
Guanidine—Ecchymosis—Leflunomide—systemic scleroderma	0.0041	0.00683	CcSEcCtD
Guanidine—Ecchymosis—Mycophenolic acid—systemic scleroderma	0.00391	0.00652	CcSEcCtD
Guanidine—Sweating—Pentoxifylline—systemic scleroderma	0.0039	0.00649	CcSEcCtD
Guanidine—KCNH6—lung—systemic scleroderma	0.00388	0.00971	CbGeAlD
Guanidine—Ataxia—Captopril—systemic scleroderma	0.00376	0.00626	CcSEcCtD
Guanidine—KCNQ1—digestive system—systemic scleroderma	0.00374	0.00937	CbGeAlD
Guanidine—KCNA1—tendon—systemic scleroderma	0.0037	0.00926	CbGeAlD
Guanidine—Azotaemia—Methotrexate—systemic scleroderma	0.00363	0.00605	CcSEcCtD
Guanidine—ALDH2—connective tissue—systemic scleroderma	0.00361	0.00904	CbGeAlD
Guanidine—Lightheadedness—Lisinopril—systemic scleroderma	0.00349	0.00581	CcSEcCtD
Guanidine—Flushing—Pentoxifylline—systemic scleroderma	0.00339	0.00564	CcSEcCtD
Guanidine—Atrial fibrillation—Mycophenolic acid—systemic scleroderma	0.00332	0.00552	CcSEcCtD
Guanidine—ALDH2—smooth muscle tissue—systemic scleroderma	0.0033	0.00827	CbGeAlD
Guanidine—ALDH2—skin of body—systemic scleroderma	0.00326	0.00817	CbGeAlD
Guanidine—KCND3—lung—systemic scleroderma	0.00323	0.00808	CbGeAlD
Guanidine—Eruption—Methotrexate—systemic scleroderma	0.00315	0.00524	CcSEcCtD
Guanidine—KCNQ1—lung—systemic scleroderma	0.00312	0.00782	CbGeAlD
Guanidine—Tension—Pentoxifylline—systemic scleroderma	0.00312	0.00519	CcSEcCtD
Guanidine—Affect lability—Mycophenolic acid—systemic scleroderma	0.00309	0.00515	CcSEcCtD
Guanidine—Ecchymosis—Mycophenolate mofetil—systemic scleroderma	0.00309	0.00514	CcSEcCtD
Guanidine—Nervousness—Pentoxifylline—systemic scleroderma	0.00309	0.00514	CcSEcCtD
Guanidine—Folliculitis—Methotrexate—systemic scleroderma	0.00308	0.00513	CcSEcCtD
Guanidine—Psychotic disorder—Mycophenolic acid—systemic scleroderma	0.00307	0.00511	CcSEcCtD
Guanidine—Liver function test abnormal—Leflunomide—systemic scleroderma	0.00304	0.00506	CcSEcCtD
Guanidine—Atrial fibrillation—Lisinopril—systemic scleroderma	0.00299	0.00497	CcSEcCtD
Guanidine—Mood swings—Mycophenolic acid—systemic scleroderma	0.00298	0.00496	CcSEcCtD
Guanidine—Tremor—Pentoxifylline—systemic scleroderma	0.00298	0.00495	CcSEcCtD
Guanidine—Ataxia—Mycophenolic acid—systemic scleroderma	0.00296	0.00492	CcSEcCtD
Guanidine—Anaemia—Pentoxifylline—systemic scleroderma	0.00294	0.00489	CcSEcCtD
Guanidine—Liver function test abnormal—Mycophenolic acid—systemic scleroderma	0.0029	0.00483	CcSEcCtD
Guanidine—Leukopenia—Pentoxifylline—systemic scleroderma	0.00284	0.00473	CcSEcCtD
Guanidine—Petechiae—Prednisone—systemic scleroderma	0.00282	0.00469	CcSEcCtD
Guanidine—Palpitations—Pentoxifylline—systemic scleroderma	0.00281	0.00467	CcSEcCtD
Guanidine—Hallucination—Captopril—systemic scleroderma	0.00275	0.00458	CcSEcCtD
Guanidine—SLC22A2—digestive system—systemic scleroderma	0.00275	0.00688	CbGeAlD
Guanidine—Irritability—Lisinopril—systemic scleroderma	0.0027	0.0045	CcSEcCtD
Guanidine—Ataxia—Lisinopril—systemic scleroderma	0.00266	0.00443	CcSEcCtD
Guanidine—Dry mouth—Pentoxifylline—systemic scleroderma	0.00264	0.0044	CcSEcCtD
Guanidine—Atrial fibrillation—Mycophenolate mofetil—systemic scleroderma	0.00262	0.00436	CcSEcCtD
Guanidine—Confusional state—Pentoxifylline—systemic scleroderma	0.00261	0.00435	CcSEcCtD
Guanidine—ALDH2—digestive system—systemic scleroderma	0.00261	0.00653	CbGeAlD
Guanidine—Flushing—Captopril—systemic scleroderma	0.00257	0.00427	CcSEcCtD
Guanidine—SLC22A3—connective tissue—systemic scleroderma	0.00257	0.00643	CbGeAlD
Guanidine—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00254	0.00423	CcSEcCtD
Guanidine—Tachycardia—Pentoxifylline—systemic scleroderma	0.00253	0.00421	CcSEcCtD
Guanidine—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00251	0.00417	CcSEcCtD
Guanidine—ALDH2—tendon—systemic scleroderma	0.00248	0.00622	CbGeAlD
Guanidine—Anorexia—Pentoxifylline—systemic scleroderma	0.00247	0.00411	CcSEcCtD
Guanidine—Affect lability—Mycophenolate mofetil—systemic scleroderma	0.00244	0.00406	CcSEcCtD
Guanidine—Hypotension—Pentoxifylline—systemic scleroderma	0.00242	0.00403	CcSEcCtD
Guanidine—Psychotic disorder—Mycophenolate mofetil—systemic scleroderma	0.00242	0.00403	CcSEcCtD
Guanidine—Tension—Captopril—systemic scleroderma	0.00236	0.00393	CcSEcCtD
Guanidine—Petechiae—Methotrexate—systemic scleroderma	0.00235	0.00392	CcSEcCtD
Guanidine—Mood swings—Mycophenolate mofetil—systemic scleroderma	0.00235	0.00391	CcSEcCtD
Guanidine—SLC22A3—smooth muscle tissue—systemic scleroderma	0.00235	0.00588	CbGeAlD
Guanidine—Nervousness—Captopril—systemic scleroderma	0.00234	0.00389	CcSEcCtD
Guanidine—Sweating—Mycophenolic acid—systemic scleroderma	0.00232	0.00387	CcSEcCtD
Guanidine—Liver function test abnormal—Mycophenolate mofetil—systemic scleroderma	0.00229	0.00381	CcSEcCtD
Guanidine—Dry mouth—Mometasone—systemic scleroderma	0.00228	0.0038	CcSEcCtD
Guanidine—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00225	0.00375	CcSEcCtD
Guanidine—Anaemia—Captopril—systemic scleroderma	0.00223	0.0037	CcSEcCtD
Guanidine—ALDH2—lung—systemic scleroderma	0.00218	0.00545	CbGeAlD
Guanidine—Hallucination—Mycophenolic acid—systemic scleroderma	0.00216	0.0036	CcSEcCtD
Guanidine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00214	0.00356	CcSEcCtD
Guanidine—Anorexia—Mometasone—systemic scleroderma	0.00213	0.00355	CcSEcCtD
Guanidine—Palpitations—Captopril—systemic scleroderma	0.00213	0.00354	CcSEcCtD
Guanidine—Ecchymosis—Prednisone—systemic scleroderma	0.00209	0.00349	CcSEcCtD
Guanidine—Sweating—Lisinopril—systemic scleroderma	0.00209	0.00348	CcSEcCtD
Guanidine—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00205	0.00341	CcSEcCtD
Guanidine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00205	0.00341	CcSEcCtD
Guanidine—SLC22A4—digestive system—systemic scleroderma	0.00204	0.0051	CbGeAlD
Guanidine—Paraesthesia—Mometasone—systemic scleroderma	0.00201	0.00334	CcSEcCtD
Guanidine—Dry mouth—Captopril—systemic scleroderma	0.002	0.00334	CcSEcCtD
Guanidine—Confusional state—Captopril—systemic scleroderma	0.00198	0.0033	CcSEcCtD
Guanidine—Hallucination—Lisinopril—systemic scleroderma	0.00195	0.00324	CcSEcCtD
Guanidine—Decreased appetite—Mometasone—systemic scleroderma	0.00194	0.00324	CcSEcCtD
Guanidine—Anaemia—Azathioprine—systemic scleroderma	0.00194	0.00323	CcSEcCtD
Guanidine—SLC22A4—tendon—systemic scleroderma	0.00194	0.00485	CbGeAlD
Guanidine—Thrombocytopenia—Captopril—systemic scleroderma	0.00192	0.0032	CcSEcCtD
Guanidine—Tachycardia—Captopril—systemic scleroderma	0.00192	0.00319	CcSEcCtD
Guanidine—Leukopenia—Azathioprine—systemic scleroderma	0.00188	0.00313	CcSEcCtD
Guanidine—Vascular purpura—Prednisone—systemic scleroderma	0.00188	0.00313	CcSEcCtD
Guanidine—Anorexia—Captopril—systemic scleroderma	0.00187	0.00312	CcSEcCtD
Guanidine—Tension—Mycophenolic acid—systemic scleroderma	0.00186	0.00309	CcSEcCtD
Guanidine—Nervousness—Mycophenolic acid—systemic scleroderma	0.00184	0.00306	CcSEcCtD
Guanidine—Hypotension—Captopril—systemic scleroderma	0.00184	0.00306	CcSEcCtD
Guanidine—Anaemia—Leflunomide—systemic scleroderma	0.00183	0.00305	CcSEcCtD
Guanidine—Sweating—Mycophenolate mofetil—systemic scleroderma	0.00183	0.00305	CcSEcCtD
Guanidine—Flushing—Lisinopril—systemic scleroderma	0.00182	0.00303	CcSEcCtD
Guanidine—Leukopenia—Leflunomide—systemic scleroderma	0.00178	0.00296	CcSEcCtD
Guanidine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00177	0.00295	CcSEcCtD
Guanidine—Tremor—Mycophenolic acid—systemic scleroderma	0.00177	0.00295	CcSEcCtD
Guanidine—Abdominal pain—Mometasone—systemic scleroderma	0.00177	0.00294	CcSEcCtD
Guanidine—Body temperature increased—Mometasone—systemic scleroderma	0.00177	0.00294	CcSEcCtD
Guanidine—Paraesthesia—Captopril—systemic scleroderma	0.00176	0.00294	CcSEcCtD
Guanidine—Palpitations—Leflunomide—systemic scleroderma	0.00175	0.00292	CcSEcCtD
Guanidine—Ecchymosis—Methotrexate—systemic scleroderma	0.00175	0.00291	CcSEcCtD
Guanidine—Anaemia—Mycophenolic acid—systemic scleroderma	0.00175	0.00291	CcSEcCtD
Guanidine—Purpura—Prednisone—systemic scleroderma	0.00174	0.0029	CcSEcCtD
Guanidine—Dizziness—Pentoxifylline—systemic scleroderma	0.00171	0.00285	CcSEcCtD
Guanidine—Decreased appetite—Captopril—systemic scleroderma	0.00171	0.00284	CcSEcCtD
Guanidine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00171	0.00284	CcSEcCtD
Guanidine—SLC22A4—lung—systemic scleroderma	0.0017	0.00426	CbGeAlD
Guanidine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00169	0.00282	CcSEcCtD
Guanidine—SLC22A5—skin of body—systemic scleroderma	0.00168	0.00422	CbGeAlD
Guanidine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00168	0.00279	CcSEcCtD
Guanidine—Tension—Lisinopril—systemic scleroderma	0.00167	0.00278	CcSEcCtD
Guanidine—Palpitations—Mycophenolic acid—systemic scleroderma	0.00167	0.00278	CcSEcCtD
Guanidine—Nervousness—Lisinopril—systemic scleroderma	0.00166	0.00276	CcSEcCtD
Guanidine—Affect lability—Prednisone—systemic scleroderma	0.00165	0.00275	CcSEcCtD
Guanidine—Dry mouth—Leflunomide—systemic scleroderma	0.00165	0.00275	CcSEcCtD
Guanidine—Psychotic disorder—Prednisone—systemic scleroderma	0.00164	0.00273	CcSEcCtD
Guanidine—Rash—Pentoxifylline—systemic scleroderma	0.00163	0.00272	CcSEcCtD
Guanidine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00163	0.00272	CcSEcCtD
Guanidine—Feeling abnormal—Captopril—systemic scleroderma	0.00162	0.0027	CcSEcCtD
Guanidine—Irritability—Prednisone—systemic scleroderma	0.0016	0.00267	CcSEcCtD
Guanidine—Hypotension—Azathioprine—systemic scleroderma	0.0016	0.00267	CcSEcCtD
Guanidine—Tremor—Lisinopril—systemic scleroderma	0.0016	0.00266	CcSEcCtD
Guanidine—Mood swings—Prednisone—systemic scleroderma	0.00159	0.00265	CcSEcCtD
Guanidine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00159	0.00264	CcSEcCtD
Guanidine—Tachycardia—Leflunomide—systemic scleroderma	0.00158	0.00263	CcSEcCtD
Guanidine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00158	0.00262	CcSEcCtD
Guanidine—Anaemia—Lisinopril—systemic scleroderma	0.00158	0.00262	CcSEcCtD
Guanidine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00157	0.00261	CcSEcCtD
Guanidine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00156	0.00259	CcSEcCtD
Guanidine—Body temperature increased—Captopril—systemic scleroderma	0.00155	0.00259	CcSEcCtD
Guanidine—Abdominal pain—Captopril—systemic scleroderma	0.00155	0.00259	CcSEcCtD
Guanidine—SLC22A3—lung—systemic scleroderma	0.00155	0.00388	CbGeAlD
Guanidine—Anorexia—Leflunomide—systemic scleroderma	0.00154	0.00257	CcSEcCtD
Guanidine—Nausea—Pentoxifylline—systemic scleroderma	0.00154	0.00256	CcSEcCtD
Guanidine—Diarrhoea—Mometasone—systemic scleroderma	0.00153	0.00255	CcSEcCtD
Guanidine—Leukopenia—Lisinopril—systemic scleroderma	0.00153	0.00254	CcSEcCtD
Guanidine—Hypotension—Leflunomide—systemic scleroderma	0.00151	0.00252	CcSEcCtD
Guanidine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00151	0.00252	CcSEcCtD
Guanidine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00151	0.00251	CcSEcCtD
Guanidine—Palpitations—Lisinopril—systemic scleroderma	0.00151	0.00251	CcSEcCtD
Guanidine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00149	0.00249	CcSEcCtD
Guanidine—Anorexia—Mycophenolic acid—systemic scleroderma	0.00147	0.00245	CcSEcCtD
Guanidine—Tension—Mycophenolate mofetil—systemic scleroderma	0.00147	0.00244	CcSEcCtD
Guanidine—Paraesthesia—Leflunomide—systemic scleroderma	0.00145	0.00242	CcSEcCtD
Guanidine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00145	0.00242	CcSEcCtD
Guanidine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00144	0.0024	CcSEcCtD
Guanidine—Dry mouth—Lisinopril—systemic scleroderma	0.00142	0.00236	CcSEcCtD
Guanidine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00141	0.00235	CcSEcCtD
Guanidine—Rash—Mometasone—systemic scleroderma	0.00141	0.00235	CcSEcCtD
Guanidine—Dermatitis—Mometasone—systemic scleroderma	0.00141	0.00235	CcSEcCtD
Guanidine—Decreased appetite—Leflunomide—systemic scleroderma	0.00141	0.00234	CcSEcCtD
Guanidine—Confusional state—Lisinopril—systemic scleroderma	0.0014	0.00234	CcSEcCtD
Guanidine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.0014	0.00233	CcSEcCtD
Guanidine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00139	0.00231	CcSEcCtD
Guanidine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00138	0.0023	CcSEcCtD
Guanidine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00136	0.00227	CcSEcCtD
Guanidine—Tachycardia—Lisinopril—systemic scleroderma	0.00136	0.00226	CcSEcCtD
Guanidine—Abdominal pain—Azathioprine—systemic scleroderma	0.00136	0.00226	CcSEcCtD
Guanidine—Body temperature increased—Azathioprine—systemic scleroderma	0.00136	0.00226	CcSEcCtD
Guanidine—SLC22A5—digestive system—systemic scleroderma	0.00135	0.00338	CbGeAlD
Guanidine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00135	0.00224	CcSEcCtD
Guanidine—Diarrhoea—Captopril—systemic scleroderma	0.00134	0.00224	CcSEcCtD
Guanidine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00134	0.00224	CcSEcCtD
Guanidine—Irritability—Methotrexate—systemic scleroderma	0.00134	0.00223	CcSEcCtD
Guanidine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00223	CcSEcCtD
Guanidine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00133	0.00222	CcSEcCtD
Guanidine—Mood swings—Methotrexate—systemic scleroderma	0.00133	0.00222	CcSEcCtD
Guanidine—Nausea—Mometasone—systemic scleroderma	0.00133	0.00221	CcSEcCtD
Guanidine—Anorexia—Lisinopril—systemic scleroderma	0.00133	0.00221	CcSEcCtD
Guanidine—Ataxia—Methotrexate—systemic scleroderma	0.00132	0.0022	CcSEcCtD
Guanidine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00132	0.0022	CcSEcCtD
Guanidine—Hypotension—Lisinopril—systemic scleroderma	0.0013	0.00216	CcSEcCtD
Guanidine—Dizziness—Captopril—systemic scleroderma	0.0013	0.00216	CcSEcCtD
Guanidine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.0013	0.00216	CcSEcCtD
Guanidine—SLC22A5—tendon—systemic scleroderma	0.00128	0.00321	CbGeAlD
Guanidine—Body temperature increased—Leflunomide—systemic scleroderma	0.00128	0.00213	CcSEcCtD
Guanidine—Abdominal pain—Leflunomide—systemic scleroderma	0.00128	0.00213	CcSEcCtD
Guanidine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00127	0.00212	CcSEcCtD
Guanidine—Paraesthesia—Lisinopril—systemic scleroderma	0.00125	0.00208	CcSEcCtD
Guanidine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00207	CcSEcCtD
Guanidine—Rash—Captopril—systemic scleroderma	0.00124	0.00206	CcSEcCtD
Guanidine—Dermatitis—Captopril—systemic scleroderma	0.00124	0.00206	CcSEcCtD
Guanidine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00205	CcSEcCtD
Guanidine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00122	0.00203	CcSEcCtD
Guanidine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00122	0.00203	CcSEcCtD
Guanidine—Decreased appetite—Lisinopril—systemic scleroderma	0.00121	0.00201	CcSEcCtD
Guanidine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00199	CcSEcCtD
Guanidine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00198	CcSEcCtD
Guanidine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00196	CcSEcCtD
Guanidine—Diarrhoea—Azathioprine—systemic scleroderma	0.00117	0.00195	CcSEcCtD
Guanidine—Nausea—Captopril—systemic scleroderma	0.00117	0.00194	CcSEcCtD
Guanidine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00193	CcSEcCtD
Guanidine—Hallucination—Prednisone—systemic scleroderma	0.00116	0.00193	CcSEcCtD
Guanidine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00115	0.00191	CcSEcCtD
Guanidine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00114	0.0019	CcSEcCtD
Guanidine—Dizziness—Azathioprine—systemic scleroderma	0.00113	0.00189	CcSEcCtD
Guanidine—SLC22A5—lung—systemic scleroderma	0.00113	0.00282	CbGeAlD
Guanidine—Diarrhoea—Leflunomide—systemic scleroderma	0.00111	0.00184	CcSEcCtD
Guanidine—Body temperature increased—Lisinopril—systemic scleroderma	0.0011	0.00183	CcSEcCtD
Guanidine—Abdominal pain—Lisinopril—systemic scleroderma	0.0011	0.00183	CcSEcCtD
Guanidine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00182	CcSEcCtD
Guanidine—Rash—Azathioprine—systemic scleroderma	0.00108	0.0018	CcSEcCtD
Guanidine—Dermatitis—Azathioprine—systemic scleroderma	0.00108	0.0018	CcSEcCtD
Guanidine—Flushing—Prednisone—systemic scleroderma	0.00108	0.0018	CcSEcCtD
Guanidine—Dizziness—Leflunomide—systemic scleroderma	0.00107	0.00178	CcSEcCtD
Guanidine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00176	CcSEcCtD
Guanidine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00106	0.00176	CcSEcCtD
Guanidine—Sweating—Methotrexate—systemic scleroderma	0.00104	0.00173	CcSEcCtD
Guanidine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00102	0.0017	CcSEcCtD
Guanidine—Rash—Leflunomide—systemic scleroderma	0.00102	0.0017	CcSEcCtD
Guanidine—Dermatitis—Leflunomide—systemic scleroderma	0.00102	0.0017	CcSEcCtD
Guanidine—Nausea—Azathioprine—systemic scleroderma	0.00102	0.0017	CcSEcCtD
Guanidine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.001	0.00167	CcSEcCtD
Guanidine—Rash—Mycophenolic acid—systemic scleroderma	0.000974	0.00162	CcSEcCtD
Guanidine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000973	0.00162	CcSEcCtD
Guanidine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000964	0.0016	CcSEcCtD
Guanidine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000964	0.0016	CcSEcCtD
Guanidine—Nausea—Leflunomide—systemic scleroderma	0.000962	0.0016	CcSEcCtD
Guanidine—Diarrhoea—Lisinopril—systemic scleroderma	0.000952	0.00158	CcSEcCtD
Guanidine—Anaemia—Prednisone—systemic scleroderma	0.000936	0.00156	CcSEcCtD
Guanidine—Dizziness—Lisinopril—systemic scleroderma	0.00092	0.00153	CcSEcCtD
Guanidine—Nausea—Mycophenolic acid—systemic scleroderma	0.000918	0.00153	CcSEcCtD
Guanidine—Rash—Lisinopril—systemic scleroderma	0.000877	0.00146	CcSEcCtD
Guanidine—Dermatitis—Lisinopril—systemic scleroderma	0.000876	0.00146	CcSEcCtD
Guanidine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000834	0.00139	CcSEcCtD
Guanidine—Nausea—Lisinopril—systemic scleroderma	0.000826	0.00138	CcSEcCtD
Guanidine—Tachycardia—Prednisone—systemic scleroderma	0.000807	0.00134	CcSEcCtD
Guanidine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000806	0.00134	CcSEcCtD
Guanidine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000799	0.00133	CcSEcCtD
Guanidine—Anorexia—Prednisone—systemic scleroderma	0.000788	0.00131	CcSEcCtD
Guanidine—Anaemia—Methotrexate—systemic scleroderma	0.000782	0.0013	CcSEcCtD
Guanidine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000769	0.00128	CcSEcCtD
Guanidine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000768	0.00128	CcSEcCtD
Guanidine—Leukopenia—Methotrexate—systemic scleroderma	0.000757	0.00126	CcSEcCtD
Guanidine—Paraesthesia—Prednisone—systemic scleroderma	0.000742	0.00124	CcSEcCtD
Guanidine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000724	0.00121	CcSEcCtD
Guanidine—Decreased appetite—Prednisone—systemic scleroderma	0.000718	0.0012	CcSEcCtD
Guanidine—Confusional state—Methotrexate—systemic scleroderma	0.000696	0.00116	CcSEcCtD
Guanidine—Feeling abnormal—Prednisone—systemic scleroderma	0.000681	0.00113	CcSEcCtD
Guanidine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000676	0.00113	CcSEcCtD
Guanidine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000668	0.00111	CcSEcCtD
Guanidine—Anorexia—Methotrexate—systemic scleroderma	0.000658	0.0011	CcSEcCtD
Guanidine—Abdominal pain—Prednisone—systemic scleroderma	0.000653	0.00109	CcSEcCtD
Guanidine—Body temperature increased—Prednisone—systemic scleroderma	0.000653	0.00109	CcSEcCtD
Guanidine—Hypotension—Methotrexate—systemic scleroderma	0.000645	0.00107	CcSEcCtD
Guanidine—Paraesthesia—Methotrexate—systemic scleroderma	0.00062	0.00103	CcSEcCtD
Guanidine—Decreased appetite—Methotrexate—systemic scleroderma	0.0006	0.000999	CcSEcCtD
Guanidine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000569	0.000947	CcSEcCtD
Guanidine—Diarrhoea—Prednisone—systemic scleroderma	0.000565	0.000941	CcSEcCtD
Guanidine—Dizziness—Prednisone—systemic scleroderma	0.000546	0.00091	CcSEcCtD
Guanidine—Abdominal pain—Methotrexate—systemic scleroderma	0.000546	0.000909	CcSEcCtD
Guanidine—Body temperature increased—Methotrexate—systemic scleroderma	0.000546	0.000909	CcSEcCtD
Guanidine—Rash—Prednisone—systemic scleroderma	0.000521	0.000867	CcSEcCtD
Guanidine—Dermatitis—Prednisone—systemic scleroderma	0.000521	0.000867	CcSEcCtD
Guanidine—Nausea—Prednisone—systemic scleroderma	0.000491	0.000817	CcSEcCtD
Guanidine—Diarrhoea—Methotrexate—systemic scleroderma	0.000473	0.000787	CcSEcCtD
Guanidine—Dizziness—Methotrexate—systemic scleroderma	0.000457	0.00076	CcSEcCtD
Guanidine—Rash—Methotrexate—systemic scleroderma	0.000435	0.000725	CcSEcCtD
Guanidine—Dermatitis—Methotrexate—systemic scleroderma	0.000435	0.000724	CcSEcCtD
Guanidine—Nausea—Methotrexate—systemic scleroderma	0.00041	0.000683	CcSEcCtD
